PRONTO-HNProactive Care Coordination for Head and Neck Cancer Surgery
Proactive Risk-Based Optimization and Notifications for Treatment and Outcomes (PRONTO)
Squamous Cell Carcinoma of Head and Neck+8
+ Carcinoma
+ Carcinoma, Squamous Cell
Services Research Study
Summary
Study start date: August 21, 2025
Actual date on which the first participant was enrolled.This study focuses on improving the timing of post-surgery treatments for head and neck cancer patients. Often, there are delays in starting radiotherapy after surgery, which can lead to worse health outcomes. The study is exploring whether a new system called PRONTO-HN can help keep these delays to a minimum, ideally under 42 days, at a specific hospital in Montreal. The system sends automated alerts and coordinates tasks among different healthcare providers to ensure timely treatment. By improving the process, the study aims to enhance survival rates and overall outcomes for patients undergoing postoperative care for head and neck cancer. Participants in this study are divided into two groups. The first group includes patients who received care before the new system was implemented, while the second group includes those treated with the new coordination system. The intervention involves automated alerts and risk assessments to help prioritize and coordinate care more efficiently. The study collects data on each patient's demographics and medical history without requiring their consent, as the intervention is administrative. Researchers will analyze the effectiveness of the system by looking at how well it reduces treatment delays and improves patient outcomes. A smaller group of patients is being studied to see if the new system can significantly reduce the number of patients experiencing delays longer than 42 days.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.85 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Services Research Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Centre Hospitalier de l'Université de Montréal
Montreal, CanadaOpen Centre Hospitalier de l'Université de Montréal in Google Maps